Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 18/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4419176 | 0.89 | GPR119 (0.43) | GPR119SMN1; SMN2PIK3CD | |
| SCHEMBL13598260 | 0.88 | GPR119 (0.39) | GPR119SMN1; SMN2PIK3CD | |
| SCHEMBL4552048 | 0.86 | GPR119 (0.54) | GPR119 | |
| SCHEMBL4423386 | 0.86 | GPR119 (0.43) | GPR119SMN1; SMN2 | |
| SCHEMBL4415920 | 0.86 | GPR119 (0.54) | GPR119 | |
| SCHEMBL4422114 | 0.85 | GPR119 (0.46) | GPR119 | |
| SCHEMBL4562543 | 0.83 | GPR119 (0.43) | GPR119SMN1; SMN2 | |
| SCHEMBL28776200 | 0.80 | GPR119 (0.40) | GPR119 | |
| SCHEMBL4426110 | 0.79 | GPR119 (0.53) | GPR119 | |
| SCHEMBL4415809 | 0.79 | GPR119 (0.53) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325924-A1 | GPCR Agonists | PROSIDION LIMITED (GB) | 2009-12-31 | — | — | US | disclosed |
| US-20090325924-A1 | GPCR Agonists | PROSIDION LIMITED (GB) | 2009-12-31 | — | — | US | disclosed |
| US-20090325924-A1 | GPCR Agonists | PROSIDION LIMITED (GB) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325924-A1 | GPCR Agonists | GPR119, GCGR, GPR27 | GPR119 1/4885SMN1; SMN2 2663/4885PIK3CD 2081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.